Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae
dc.contributor.author | Calvo, Almudena | |
dc.contributor.author | Giménez, María José | |
dc.contributor.author | Alou Cervera, Luis | |
dc.contributor.author | Gómez-Lus Centelles, María Luisa | |
dc.contributor.author | Aguilar, Lorenzo | |
dc.contributor.author | Prieto Prieto, José | |
dc.date.accessioned | 2024-07-24T07:26:35Z | |
dc.date.available | 2024-07-24T07:26:35Z | |
dc.date.issued | 2002-08 | |
dc.description.department | Depto. de Medicina | |
dc.description.faculty | Fac. de Medicina | |
dc.description.refereed | TRUE | |
dc.description.status | pub | |
dc.identifier.citation | Calvo A, Giménez MJ, Alou L, Gómez-Lus ML, Aguilar L, Prieto J. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae. Int J Antimicrob Agents. 2002 Aug;20(2):144-6. | |
dc.identifier.doi | 10.1016/s0924-8579(02)00119-x | |
dc.identifier.issn | 0924-8579 | |
dc.identifier.officialurl | https://doi.org/10.1016/S0924-8579(02)00119-X | |
dc.identifier.relatedurl | https://www.sciencedirect.com/science/article/pii/S092485790200119X | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/107072 | |
dc.issue.number | 2 | |
dc.journal.title | International Journal of Antimicrobial Agents | |
dc.language.iso | eng | |
dc.page.final | 146 | |
dc.page.initial | 144 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | restricted access | |
dc.subject.cdu | 611.02 | |
dc.subject.keyword | Ex vivo activity | |
dc.subject.keyword | Killing rates | |
dc.subject.keyword | Gemifloxacin | |
dc.subject.keyword | Streptococcus pneumoniae | |
dc.subject.ucm | Microbiología médica | |
dc.subject.unesco | 2414 Microbiología | |
dc.title | Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 20 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 889e4dc3-c630-429e-be0f-7f0df2cff492 | |
relation.isAuthorOfPublication | f7ad336e-4779-4665-9893-44b47bed8a7a | |
relation.isAuthorOfPublication | 84cd82de-c5ea-4fed-a347-4ed15fb3bcc8 | |
relation.isAuthorOfPublication.latestForDiscovery | 889e4dc3-c630-429e-be0f-7f0df2cff492 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2002 IJAA Calvo gemifloxacono Letter.pdf
- Size:
- 91.04 KB
- Format:
- Adobe Portable Document Format